SCHEMBL7573973

SCHEMBL7573973

COC(=O)c1cc(NS(=O)(=O)c2ccc(OC)cc2)c(Oc2cc(OC)ccc2Cl)c(OCCOC2CCCCO2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.42
TSHR P16473 3/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 3/20 0.41
USP2 O75604 1/20 0.41
EDNRA P25101 4/20 0.41
NPSR1 Q6W5P4 1/20 0.40
EDNRB P24530 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.38
TCF4 P15884 1/20 0.37
CTNNB1 P35222 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
MAPT P10636 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7569615 0.95 EDNRA (0.47) CYP2C9TSHRALDH1A1LMNAUSP2
SCHEMBL7568187 0.95 EDNRA (0.44) CYP2C9TSHRALDH1A1LMNAUSP2
SCHEMBL7569225 0.94 MEN1 (0.42) CYP2C9TSHRALDH1A1LMNAUSP2
SCHEMBL7570771 0.92 TSHR (0.46) CYP2C9TSHRALDH1A1LMNAUSP2
SCHEMBL7565796 0.90 EDNRA (0.47) CYP2C9TSHRALDH1A1LMNAUSP2
SCHEMBL7570355 0.90 EDNRB (0.49) CYP2C9TSHRALDH1A1LMNAUSP2
SCHEMBL7566574 0.87 EDNRA (0.44) EDNRAEDNRBNPC1RAB9A
SCHEMBL7572698 0.85 NPC1 (0.41) ALDH1A1USP2EDNRAEDNRBKDM4E
SCHEMBL7568959 0.84 EDNRB (0.47) EDNRAEDNRB
SCHEMBL7568975 0.84 EDNRA (0.47) CYP2C9ALDH1A1LMNAEDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799206-B1 ARYL- AND HETARYL-SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6133442-A FOR THE TREATMENT OF DISORDERS WHICH ARE ASSOCIATED WITH ENDOTHELIN ACTIVITIES, ESPECIALLY CIRCULATORY DISORDERS SUCH AS HYPERTENSION, ISCHAEMIA, VASOSPASMS AND ANGINA PECTORIS HOFFMANN-LA ROCHE INC. (US) 2000-10-17 US disclosed
US-5962682-A Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists HOFFMANN-LA ROCHE INC. (US) 1999-10-05 US disclosed
EP-0799206-A1 ARYL- AND HETARYL-SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1997-10-08 EP disclosed
WO-1996019455-A1 ARYL- AND HETARYL-SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1996-06-27 WO disclosed